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We report that the mitotic inhibitor, vinblastin (VLB), is highly toxic to the malarial parasite, Plasmodium 
falciparum. In cultures in vitro growth is inhibited by SO$ at a VLB level of about 28 nM, and totally abol- 
ished at a level of 100 nM. By tests on synchronized cultures we have found that the effect of VLB takes 
place at the trophozoite stage. Colcemid also inhibits schizogony with somewhat different kinetics. By mu- 
tagenesis with nitrosoguanidine followed by VLB selection we have isolated a VLB-resistant mutant which 
exhibits cross-resistance to vincristine. These data suggest a critical role of microtubules in the asexual schi- 
zogonic cycle of P. falciparum. 
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1. INTRODUCTION 
The intraerythrocytic development of Plas- 
modium falciparum consists of an orderly se- 
quence whereby the young ring form grows into a 
larger trophozoite with one or two nuclei, which 
within 24 h becomes a schizont with up to 24 
nuclei, giving rise, upon bursting of the host red 
cell, to a similar number of merozoites ready to in- 
vade new red cells [l]. DNA synthesis is known to 
occur during the early trophozoite stage [2,3], but 
how nuclear division exactly takes place is 
unknown. Microtubular structures have been 
observed by electron microscopy within the 
nucleus of P. galiirtaceum treated with 
pyrimethamine [4]. However, the role of these 
structures in schizogony is not yet clear. One possi- 
ble approach to defining this role is the use of 
mitotic inhibitors. In cultures of P. falciparum we 
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have found that vinblastine (VLB) totally and ir- 
reversibly interrupts the schizogonic cycle at the 
very low concentrations known to cause disruption 
of microtubules [5]. The action of the drug is en- 
tirely specific for the trophozoite stage of the 
parasite. Similar results are obtained with vin- 
cristine and with colcemid. We have also isolated 
a vinblastine-resistant mutant of P. fafciparum. 
2. MATERIALS AND METHODS 
White cell-free cultures of P. falciparum [6] (the 
Wellcome-Liverpool strain was kindly supplied by 
Dr D.C. Warhurst of the Malaria Reference 
Laboratory of the London School of Hygiene and 
Tropical Medicine) were maintained in plastic 
petric dishes (Falcon Div., Becton Dickinson, 
USA) by the candle jar method [7]. Cultures were 
synchronized by the sorbitol method [7,8] and the 
resulting ring forms were sub-cultured in 30 x 
10 mm petri dishes in complete medium (RPM1 
1640 with 25 mM Hepes, 25 mM NaHC03, 
50 pg/ml gentamycin sulphate and supplemented 
with 15% group AB human serum) or complete 
medium with the addition of the inhibitor to be 
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tested. The initial parasitaemia in each case was 
about 1% and the haematocrit of the culture 5%. 
Parasite infection rates were determined by 
counting 5000 erythrocytes per slide on Roma- 
nowsky-stained smears prepared at appropriate in- 
tervals. All inhibition experiments were carried out 
at least three times, with duplicate dishes for each 
level of drug. 
In order to test the effect of VLB on different 
stages of parasite development, synchronous 
cultures were subjected to 12 h pulses of 80 nM 
VLB in complete medium and levels of 
parasitaemia were determined at serial intervals. 
In order to isolate vinblastine-resistant (VLBR) 
mutants we have used the method described by In- 
selburg [9]. Ten 4 ml synchronized cultures in 
60 mm petri dishes, with a parasitaemia of 8%, 
were treated for 24 h with N-methyl-N-nitro-ZV- 
nitrosoguanidine (NG) (Sigma), at a final concen- 
tration of 9 PM, in complete medium. Exposure to 
the mutagen was started when parasites were be- 
tween 10 and 25 hours old, so that NG was present 
during DNA synthesis. The cultures were then 
washed twice in incomplete medium and allowed 
to go through three cycles without selection. VLB 
at 160 nM was then added to the cultures when 
parasitaemia was 8070, and it was removed after 5 
days, when parasitaemia was below 0.1%. 
Parasites started to reappear 7-14 days after the 
VLB was removed. From 14 days onwards cultures 
were maintained in 1.6 ,uM VLB. 
3. RESULTS 
3.1. Action of mitotic inhibitors 
When P. falciparum cultures are continuously 
exposed to VLB, a concentration-dependent in- 
hibition of growth is observed (fig.1). Since the 
time course of the cycle is not affected, we are 
dealing with true inhibition, rather than with mere 
slowing down of the schizogonic process. In order 
to pinpoint the stage in the cycle at which VLB 
acts, we have also exposed cultures to pulses of the 
drug, rather than to its continuous presence (fig.2). 
It is seen clearly that VLB effectively abolished 
parasite growth only when added during the 
trophozoite stage. The fact that inhibition is not as 
complete as when VLB is present throughout the 
cycle can be entirely accounted for by the fact that 
synchrony is never quite perfect. Even when the 
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Fig. 1. Inhibition of P. falciparum growth by vinblastine. 
VLB powder (Ely Lilly & Co.) was dissolved in RPM1 
1640 at 1 mg/ml, and used within 24 h. The bottom 
panel (C) shows total parasites, while the upper panels 
(A and B) show individual stages as indicated. Points up 
to 24 h are averages for all parallel cultures. Vertical 
bars in the bottom panel indicate standard deviations for 
duplicate dishes. (0) Control and 10 nM VLB; (0) 
20 nM VLB; (A) 40 nM VLB; (A) 100 nM VLB. 
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culture contained predominantly (87%) trophozo- 
ites, there were still about 13% ring forms present 
(see fig.2A), and these escaped the action of VLB. 
Colcemid similarly inhibits growth of P. 
falciparwn. However, the concentration required 
to achieve an effect comparable to that of VLB is 
about lOOO-times higher (table 1). In addition, the 
Fig.2. Stage-specificity of VLB action. Synchronized 
cultures (see fig.1) were subjected to 12 h pulses of 
80 nM VLB. Top panels: (A-C) distribution of different 
forms of the parasite as a function of time in control 
cultures. Sharp successive peaks of trophozoites and 
schizonts indicate good synchrony of the cultures. (D) 
Marked differences in VLB effect depending on choice 
of timing of exposure to drug across the parasite cycle. 
The zig-zag lines at the bottom (E) indicate the period 
during which VLB was present in five otherwise identical 
dishes. These are identified by the numbers on the left, 
with which the growth curves are also labelled. Arrow at 
the top of panel D indicates dilution of the culture (1: 6). 
nature of inhibition is different, because when the 
drug is removed after a 24-h exposure growth 
resumes with a 24-h delay (fig.3). 
3.2. Isolation of vinblastine-resistant mutants 
Mutagenesis with NG was carried out under con- 
ditions producing about 90% parasite mortality 
(see section 2). After NG treatment cultures were 
allowed to undergo three successive schizogonic 
cycles and they were then challenged with 1.6 PM 
VLB. Within three cycles parasites became 
undetectable by conventional microscopic ex- 
amination, but they started to reappear after about 
14 days, and continued to grow in VLB indefinitely 
(over 100 days). In order to make sure that VLB- 
resistance was due to a genetic and not to an adap- 
tive change, the culture was split and one aliquot 
Table 1 
Drug sensitivity of Plasmodium falciparum 
Drug LDsoa 
WL VLBR 
Vinblastine 15-30 nMb 1.2-4.4 pMb 
(3.2 ,uM)~ 
Vincristine 7nM f/M 
Colcemid 50 ,uM not done 
Chloroquine 72 nM 45 nM 
a Drug concentration causing 50% reduction in parasite 
level after 48 h exposure. Values are means of 
duplicate experiments unless stated otherwise 
b Range of values in four sets of experiments 
’ After 30 days of growth in the absence of VLB 
2s 
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Fig.3. Plasmodiostatic effect of colcemid vs stage- 
specific killing by vinblastine. Left panel: (0) control 
culture; (A) VLB (80 nM) present only from 0 to 24 h; 
(A) VLB (80 nM) removed at 48 h. Right panel: (0) 
control culture; (0) colcemid (5OOrM) present only 
from 0 to 24 h; (0) colcemid (500 FM) removed at 48 h. 
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Fig.4. Dose-response curve of effect of anti-mitotic 
drugs on parasite growth. In the control culture parasites 
at 48 h were 92 per 1000 erythrocytes (= 100%). 
was grown for 30 days in the absence of the drug. 
After repeated challenge, vinblastine-resistance 
was confirmed (see table 1). Our VLBR mutant 
tolerates a drug concentration about lOO-times 
higher than the strain from which it derives (fig.4). 
The VLBR mutant exhibits cross-resistance also to 
vincristine. On the other hand, both strains have 
the same level of sensitivity to the well known an- 
timalarial agent, chloroquine (table 1). 
4. DISCUSSION 
The best evidence thus far for the role of 
microtubular formations in nuclear division in 
Plusmodia has come from ultrastructural work 
carried out on P. berghei. Spindle structures have 
been observed both in ookinetes in the mosquito 
[lo] and in exoerythrocytic stages in mouse liver 
[l 11. By contrast, no information is available on 
the blood forms of P. falciparum. Our data in- 
dicate that VLB interferes with an event in the 
schizogonic cycle which takes place specifically at 
the trophozoite stage. In animal cells VLB is 
known to prevent the formation of mitotic spindle 
microtubules [12,13]. In order to corroborate the 
idea that the same may be true in Plasmodium, we 
have carried out similar experiments with other 
mitotic inhibitors such as vincristine and colcemid 
(which have been used in the treatment of human 
malaria [14]). We have found that parasite 
development is again blocked at the trophozoite 
stage. However, with colcemid higher concentra- 
tions are needed (50pM for 50% inhibition), and 
the block is to some extent reversible upon removal 
of the drug. 
Although it is possible that these agents affect 
Plasmodium by a different mechanism, the irrever- 
sibility of VLB action versus the reversibility of 
colcemid inhibition is consistent with the known 
effects of these agents on animal cells, whereby the 
former produces disruption of microtubules while 
the latter merely prevents polymerization of 
tubulins [12]. In addition, the observation that 
VLB blocks the cycle at very low concentrations 
suggests that its highly specific interaction with 
tubulin is involved. The most likely conclusion is 
that the spindle apparatus is, indeed, essential for 
nuclear division in the schizogonic cycle of P. 
falciparum. Previously, Sinden and Smalley [15] 
had reported a ‘lethal effect’ of colchicine in vitro 
on asexual forms from patients with clinical 
malaria, and the same agent has been used to syn- 
chronize cultures [ 161. Taxol, an agent that inhibits 
dissociation of tubulin subunits [ 171 blocks replica- 
tion of Trypanosoma cruzi [18]. No information 
was previously available on VLB in protozoa. 
If susceptibility to microtubule reagents is taken 
26 
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to indicate that these structures have a role in 
nuclear division, the timing of the latter would be 
very close to that of DNA synthesis [2]. This 
finding is consistent with previous evidence by 
Gutteridge and Trigg [3] that there is little or no GZ 
phase in P. knowlesi, and it points to a significant 
difference in the division cycle between this 
parasitic protozoon and most animal cells. Since 
VLB is effective only against trophozoites it ap- 
pears that tubulins are either present or accessible 
to the drug only at this stage. 
The specificity of VLB action on P. faiciparum 
is supported by our ability to isolate a drug- 
resistant derivative strain, under conditions which 
presumably selected for a single-step mutant. The 
mutant exhibits cross-resistance to the related 
drug, vincristine. We do not yet know whether 
VLB-resistance is due to decreased rug uptake by 
the parasite or to an intracellular effect. However, 
the mutational change is not unspecific, since sen- 
sitivity of the parasite to chloroquine is not af- 
fected. If the mutation involves microtubules, the 
VLBR mutant might help to understand the func- 
tion of these structures in the parasite cycle. 
Similar mutants have been described in a variety of 
organisms [19]. At a time when the progressive 
spread of drug-resistant P. falciparum is causing 
grave concern [20] it may be important to increase 
the range of agents that can block the parasite cy- 
cle in a characteristic way. 
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